This may be due to increased activation of SREBP2, the principal activator for HMGCR, which seems specific for NAFLD patients as it was not shown in weight-matched obese or hepatitis C patients as controls [28]. The gene discussed is HMGCR; the disease is hepatitis C virus infection.